Welcome to LookChem.com Sign In|Join Free
  • or
3-(benzoxazol-2-yl)-7-(diethylamino)-2-benzopyrone is a synthetic chemical compound characterized by a complex structure that includes a benzoxazole ring, a diethylamino group, and a benzopyrone core. 3-(benzoxazol-2-yl)-7-(diethylamino)-2-benzopyrone is known for its unique fluorescent properties, which arise from the presence of the benzoxazole and benzopyrone components. The diethylamino group further contributes to its potential as a pharmaceutical agent by possibly enhancing its pharmacokinetic properties, such as targeted delivery and improved bioavailability.

35773-42-3

Post Buying Request

35773-42-3 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

35773-42-3 Usage

Uses

Used in Chemical Research:
3-(benzoxazol-2-yl)-7-(diethylamino)-2-benzopyrone is used as a fluorescent probe for the detection of metal ions in biological systems. Its fluorescent properties make it a valuable tool in chemical research for studying interactions between metal ions and biological molecules.
Used in Biological Imaging and Sensing:
In the field of biological imaging and sensing, 3-(benzoxazol-2-yl)-7-(diethylamino)-2-benzopyrone is used as a fluorescent marker. Its ability to emit fluorescence upon interaction with metal ions allows researchers to track and visualize these ions within biological systems, which is crucial for understanding their roles in various biological processes.
Used in Pharmaceutical Development:
3-(benzoxazol-2-yl)-7-(diethylamino)-2-benzopyrone is used as a potential pharmaceutical agent. The diethylamino group may enhance the compound's pharmacokinetic properties, such as targeted delivery and improved bioavailability, making it a promising candidate for drug development in various therapeutic areas.

Check Digit Verification of cas no

The CAS Registry Mumber 35773-42-3 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 3,5,7,7 and 3 respectively; the second part has 2 digits, 4 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 35773-42:
(7*3)+(6*5)+(5*7)+(4*7)+(3*3)+(2*4)+(1*2)=133
133 % 10 = 3
So 35773-42-3 is a valid CAS Registry Number.
InChI:InChI=1/C20H18N2O3/c1-3-22(4-2)14-10-9-13-11-15(20(23)25-18(13)12-14)19-21-16-7-5-6-8-17(16)24-19/h5-12H,3-4H2,1-2H3

35773-42-3SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 13, 2017

Revision Date: Aug 13, 2017

1.Identification

1.1 GHS Product identifier

Product name 3-(2-benzoxazolyl)-7-(diethylamino)-2H-1-benzopyran-2-one

1.2 Other means of identification

Product number -
Other names 3-benzooxazol-2-yl-7-diethylamino-chromen-2-one

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:35773-42-3 SDS

35773-42-3Downstream Products

35773-42-3Relevant academic research and scientific papers

Synthesis, photo-and electro-luminescence of 3-benzoxazol-2-yl-coumarin derivatives

Zhao, Yuling,Yu, Tianzhi,Wu, Youzhi,Zhang, Hui,Fan, Duowang,Gan, Zunwei,Yang, Liangliang,Han, Xiaoqian,Zhang, Yumei

, p. 631 - 638 (2012)

Two coumarin derivatives containing electrontransporting benzoxazolyl moiety, 7-(diethylamino)-3- (benzoxazol-2-yl)coumarin (DABOC) and 3-(benzoxazol- 2-yl)benzo[5,6]coumarin (BOBC), were synthesized and characterized. The photoluminescence and electroluminescence of the compounds were investigated detailedly. The compounds exhibited strong blue-green emissions in both solution and solid states, but the devices with DABOC as the emitting layer exhibited orange emission and maximum luminous efficiency of 2.8 cd/A and maximum luminance of 8,800 cd/m2, and the devices with BOBC displayed orange-white emission and maximum luminous efficiency of 0.13 cd/A and maximum luminance of 540 cd/m2. Springer Science+Business Media, LLC 2011.

Discovery of fluorescent 3-heteroarylcoumarin derivatives as novel inhibitors of anaplastic lymphoma kinase

Mah, Shinmee,Song, Daesun,Shin, Yongje,Jung, Yongwon,Hong, Sungwoo,Jang, Jaebong,Latif, Muhammad

, p. 186 - 194 (2019/01/11)

Altered expression or hyperactivation of anaplastic lymphoma kinase (ALK), as a consequence of translocations or point mutations, is one of the main oncogenic drivers in non-small cell lung cancer. Using structure-based design and in vitro enzyme assays, we identified 3-heteroarylcoumarin as a new template for the development of novel fluorescent ALK inhibitors. Molecular simulation provided structural insights for the design of 3-heteroarylcoumarin derivatives, which were easily prepared through efficient synthetic approaches including direct C-H cross coupling. Importantly, these coumarin-based ALK inhibitors can be tracked using microscopy techniques: we illustrated the use of the most potent compound in this series, 5a, (ALK/IC50 = 0.51 μM, λemi = 500 nm, φF = 0.29) to monitor its subcellular distribution pattern by confocal fluorescence microscopy.

Organic–inorganic hybrid material, dichloro N,N'-(1,2-phenylene)bis(2-aminobenzamide) cobalt(II)@Al-SBA-15: an environment friendly catalyst for the synthesis of 3-benzoxazol-2-yl-chromen-2-ones

Safaei Ghomi, Javad,Akbarzadeh, Zeinab,Bakhtiari, Atefeh

, p. 826 - 840 (2019/05/17)

A new organic-inorganic hybrid material, CoCl2N,N'-(1,2-phenylene)bis(2-aminobenzamide)@Al-SBA-15, was synthesized by modification of Al-SBA-15 with (3-chloropropyl) trimethoxysilane (CPTMS), then the ligand was covalently attached to CPTMS@Al-SBA-15 and finally addition of CoCl2 to form the complex. The mesoporous CoCl2NN'PhBIA@Al-SBA-15 was an efficient catalyst in the preparation of 3-benzoxazol-2-yl-chromen-2-one derivatives through reaction of different coumarin-3-carboxylates and 2-aminophenol derivatives. The nanocatalyst increased rate and facility of the aforementioned reaction and had influence in the green synthesis of different 3-benzoxazol-2-yl-2H-chromen-2-one derivatives. The nanocatalyst was characterized by N2 adsorption–desorption, Fourier transform infrared spectroscopy (FT-IR), scanning electron microscopy (SEM), transmission electron microscopy (TEM), powder X-ray diffraction (XRD), and energy dispersive spectroscopy (EDS). Some advantages of this procedure are mild reaction condition, high yields of 3-benzoxazol-2-yl-2H-chromen-2-one, short reaction times, environmentally benign, recoverability of the catalyst and reusability without significant loss of its catalytic performance.

Discovery and Optimization of Small Molecule Splicing Modifiers of Survival Motor Neuron 2 as a Treatment for Spinal Muscular Atrophy

Woll, Matthew G.,Qi, Hongyan,Turpoff, Anthony,Zhang, Nanjing,Zhang, Xiaoyan,Chen, Guangming,Li, Chunshi,Huang, Song,Yang, Tianle,Moon, Young-Choon,Lee, Chang-Sun,Choi, Soongyu,Almstead, Neil G.,Naryshkin, Nikolai A.,Dakka, Amal,Narasimhan, Jana,Gabbeta, Vijayalakshmi,Welch, Ellen,Zhao, Xin,Risher, Nicole,Sheedy, Josephine,Weetall, Marla,Karp, Gary M.

, p. 6070 - 6085 (2016/07/26)

The underlying cause of spinal muscular atrophy (SMA) is a deficiency of the survival motor neuron (SMN) protein. Starting from hits identified in a high-throughput screening campaign and through structure-activity relationship investigations, we have developed small molecules that potently shift the alternative splicing of the SMN2 exon 7, resulting in increased production of the full-length SMN mRNA and protein. Three novel chemical series, represented by compounds 9, 14, and 20, have been optimized to increase the level of SMN protein by >50% in SMA patient-derived fibroblasts at concentrations of 160 nM. Daily administration of these compounds to severe SMA Δ7 mice results in an increased production of SMN protein in disease-relevant tissues and a significant increase in median survival time in a dose-dependent manner. Our work supports the development of an orally administered small molecule for the treatment of patients with SMA.

One-pot catalyst-free synthesis of 3-heterocyclic coumarins

Jiang, Shaoliang,Gao, Jianrong,Han, Liang

, p. 1017 - 1028 (2016/04/26)

3-Heterocyclic coumarins were prepared in one-pot three-component reaction without catalyst. The mixture of salicylaldehydes, ethyl cyanoacetate, and o-aminophenols or o-phenylenediamines in refluxing n-butanol gave title compounds with good yields and hi

Direct C-H cross-coupling approach to heteroaryl coumarins

Min, Minsik,Kim, Bomi,Hong, Sungwoo

experimental part, p. 2692 - 2698 (2012/04/23)

A Pd-catalyzed direct cross-coupling of 3-bromocoumarins with heteroarenes provided an efficient route to synthesizing 3-heteroarylcoumarins. The reaction scope for the transformation was fairly broad, affording modest to good yields of various 3-heteroarylcoumarin scaffolds, which are privileged structures and prevalent motifs in many biologically active compounds and fluorophores. The Royal Society of Chemistry 2012.

Microwave-promoted one-pot syntheses of coumarin dyes

Nourmohammadian, Farahnaz,Gholami, Mahnaz Davoodzadeh

experimental part, p. 901 - 909 (2010/05/18)

To one pot synthesis of coumarins with benzimidazol or benzoxazol moieties, three different microwave irradiations based procedures are reported here which take place within a few minutes. In spite of fairly well yield of the products using solvent free procedures, 25-30% further yields were achieved within 3 minutes at 110C using 2mL n-pentanol as solvent.

Synthesis and anti-angiogenesis activity of coumarin derivatives

Lee, Seokjoon,Sivakumar, Krishnamoorthy,Shin, Woon-Seob,Xie, Fang,Wang, Qian

, p. 4596 - 4599 (2007/10/03)

A series of 7-diethylaminocoumarin compounds were synthesized and the cytotoxicities were tested against human umbilical vein endothelial cell (HUVEC) and some cancer cells. We found that the introduction of cyano groups at the 4-position will promote the bioactivity. In particular, compounds 9 and 10 strongly inhibited the proliferation of various cancer cell lines, and 12 and 15 showed a high selectivity for HUVEC. Therefore, these coumarin molecules can be utilized as lead compounds to develop potential nontoxic angiogenesis inhibitors and small molecular ligands to target HUVEC.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 35773-42-3
  • ©2008 LookChem.com,License:ICP NO.:Zhejiang16009103 complaints:service@lookchem.com
  • [Hangzhou]86-0571-87562588,87562578,87562573 Our Legal adviser: Lawyer